Phase IA/II, multicentre, open‐label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non‐Hodgkin or Hodgkin lymphoma
暂无分享,去创建一个
M. Dyer | A. Freedman | D. Heo | A. Younes | G. Verhoef | J. Kuruvilla | B. Ewald | J. Abramson | P. Solal-Céligny | F. Offner | A. Engert | P. Corradini | M. Fanale | S. Assouline | Daniel Carreon | J. Baeck